

Health Library
October 10, 2025
Question on this topic? Get an instant answer from August.
I-Crizanlizumab iyimithi eyenzelwe ngqo ukusiza abantu abanesifo se-sickle cell ukunciphisa izinhlekelele zabo ezibuhlungu. Inikezwa ngomjovo we-IV endaweni yokunakekelwa kwezempilo, ngokuvamile kanye ngenyanga, futhi isebenza ngokuvimbela amaseli egazi ukuthi anamathele emithanjeni yakho yegazi.
Lokhu kwelashwa okuqondiwe kumelela isinyathelo esibalulekile phambili ezigulini ze-sickle cell ezihlangabezana neziqephu ezibuhlungu ezivamile. Ngokuvimba iphrotheni ethile ebangela amaseli egazi ukuthi ahlanganisane, i-crizanlizumab ingakusiza ukuthi ube nezinhlekelele ezibuhlungu ezingaphansi futhi okungenzeka ukuthi uthuthukise izinga lakho lempilo.
I-Crizanlizumab iyimithi ye-monoclonal antibody eqondise iphrotheni ebizwa nge-P-selectin emithanjeni yakho yegazi. Cabanga nge-P-selectin njengendawo enamathelayo ebangela amaseli egazi ukuthi ahlanganisane, okungavimba ukuhamba kwegazi futhi kubangele ubuhlungu obukhulu obuhambisana nezinhlekelele ze-sickle cell.
Lo muthi ukhiqizwa ngaphansi kwegama lomkhiqizo elithi Adakveo futhi ungowodwa ohlwini lwemithi ebizwa ngokuthi ama-selectin blockers. Yenziwe ngqo ukuthi ibone futhi ibophe ku-P-selectin, ngempela igcoba lezi zindawo ezinamathelayo ukuze amaseli egazi akwazi ukugeleza ngokukhululeka emithanjeni yakho.
Lokhu kuthathwa njengomuthi okhethekile ngoba kudinga ukuqapha nokuphathwa ngokucophelela endaweni yezokwelapha. Ithimba lakho lezempilo lizosebenza eduze nawe ukunquma ukuthi i-crizanlizumab iyisinqumo esifanele esimweni sakho esithile.
I-Crizanlizumab isetshenziswa ikakhulukazi ukunciphisa imvamisa yezinhlekelele ezibuhlungu ze-vaso-occlusive kubantu abanesifo se-sickle cell. Lezi zinhlekelele zenzeka lapho amaseli egazi agulayo evimba imithambo yegazi, okubangela ubuhlungu obukhulu obungahlala amahora noma izinsuku.
Umuthi uvunyelwe kubantu abadala kanye nezingane ezineminyaka engu-16 nangaphezulu abahlangabezana nezikhathi zokuhlushwa ezibuhlungu eziphindaphindayo. Akudingeki ukuthi ube nenani elithile lezikhathi zokuhlushwa ngonyaka ukuze ufaneleke, kodwa udokotela wakho uzocabangela umlando wakho wobuhlungu kanye nempilo yakho yonke lapho enquma ukuthi le mithi ifanele yini.
Ngenkathi i-crizanlizumab inganciphisa kakhulu imvamisa yezikhathi zokuhlushwa, kubalulekile ukuqonda ukuthi kungenzeka ingaqedi zonke izigameko ezibuhlungu. Abantu abaningi basahlangabezana nezinye izikhathi zokuhlushwa, kodwa zivame ukungavamile futhi ngezinye izikhathi azibi kangako kunangaphambi kokwelashwa.
I-Crizanlizumab isebenza ngokuvimba i-P-selectin, iphrotheni esebenza njenge-velcro yama-molecular ngaphakathi kwemithambo yakho yegazi. Lapho i-P-selectin isebenza, ibangela amaseli egazi, ama-platelet, nezinye izinto ukuthi zinamathele ezindongeni zemithambo yegazi kanye nakwezinye.
Esifweni samaseli e-sickle, le nqubo yokunamathela iyinkinga ngoba amaseli akho abomvu egazi asevele angalingani futhi athambekele ekubanjweni kalula. Ngokuvimba i-P-selectin, i-crizanlizumab isiza ekuvikeleni leli thrafikhi yamaselula ukuthi ingakheki endaweni yokuqala.
Lokhu kuthathwa njengomuthi oqinile ngokulinganisela mayelana nesenzo sawo esiqondiwe, kodwa usebenza ngobumnene ngokuhamba kwesikhathi kunokunikeza ukukhululeka ngokushesha. Imiphumela yakhiwa kancane kancane, yingakho ngokuvamile uzodinga ukufakwa okuningana ngaphambi kokuzwa izinzuzo ezigcwele.
I-Crizanlizumab inikezwa njengokufakwa ngomthambo ngaphezu kwemizuzu engaba ngu-30 endaweni yokunakekelwa kwezempilo. Uzothola umuthi kanye njalo emavikini amane, futhi ithimba lakho lezempilo lizokuqapha ngesikhathi nangemva kokufakwa ngakunye.
Ngaphambi kokufakwa kwakho, unganikezwa imithi yangaphambi kokwelashwa ukusiza ekuvikeleni ukusabela komzimba. Lokhu kungabandakanya ama-antihistamine, i-acetaminophen, noma ama-corticosteroids. Udokotela wakho uzokwazisa uma udinga le mithi eyengeziwe.
Akudingeki ukuthi uzile ngaphambi kokwelashwa, futhi ungadla ngokujwayelekile ngezinsuku zokufakwa. Kodwa-ke, kungumqondo omuhle ukuhlala unamanzi ngokwanele ngokuphuza amanzi amaningi ngaphambi nangemva kokuqokwa kwakho. Abanye abantu bakuthola kuwusizo ukuletha isidlo esincane nento ezobagcina bematasa ngesikhathi sokufakwa.
I-Crizanlizumab ngokuvamile iyindlela yokwelapha yesikhathi eside ozoqhubeka nayo uma nje isiza ukunciphisa izinhlekelele zakho zobuhlungu futhi ungaqali ukuzwa imiphumela emibi. Abantu abaningi bahlala emuthini izinyanga noma iminyaka.
Udokotela wakho uzohlola njalo ukuthi ukwelashwa kusebenza kahle kangakanani kuwe, ngokuvamile ngemva kwezinyanga ezimbalwa zokuqala ukwelashwa. Bazobheka ukuthi zingaki izinhlekelele zobuhlungu onazo uma ziqhathaniswa nangaphambi kokuqala i-crizanlizumab futhi baqaphele noma yimiphi imiphumela emibi.
Isinqumo sokuqhubeka noma ukuyeka ukwelashwa sizoxhomeka ekuphenduleni kwakho ngakunye kanye nanoma yiziphi izinguquko empilweni yakho yonke. Abanye abantu bangase badinge ukumisa ukwelashwa okwesikhashana uma bethola izifo noma ezinye izinkinga zempilo, kodwa abaningi bangakwazi ukuqhubeka uma sebezizwa ngcono.
Njengayo yonke imithi, i-crizanlizumab ingabangela imiphumela emibi, nakuba abantu abaningi beyibekezelela kahle. Imiphumela emibi evame kakhulu ngokuvamile ithambile futhi ilawuleka ngosizo olufanele lwezokwelapha.
Nansi imiphumela emibi ongase uyithole, ukhumbula ukuthi akubona bonke abantu abazoba nalezi zimo:
Imiphumela emibi ejwayelekile ihlanganisa:
Imiphumela emibi engavamile kodwa ebucayi ihlanganisa:
Izinkinga ezingavamile kodwa ezinzima zihlanganisa:
Ithimba lakho lezempilo lizokuqapha ngokusondele ngesikhathi sokufakwa ngakunye futhi lizokufundisa ukuthi yiziphi izimpawu zokuxwayisa okufanele uzibheke ekhaya. Imiphumela eminingi eseceleni iyalawuleka, futhi izinzuzo zokunciphisa izinhlekelele zobuhlungu zivame ukwedlula lezi zingozi ezigulini eziningi.
I-Crizanlizumab ayifanele wonke umuntu, futhi udokotela wakho uzohlola ngokucophelela ukuthi iphephile yini kuwe ngokusekelwe emlandweni wakho wezokwelapha kanye nesimo sakho sempilo samanje.
Akufanele uthole i-crizanlizumab uma wazi ukuthi unokungezwani komzimba okukhulu emuthini noma kunoma iyiphi ingxenye yawo. Udokotela wakho uzophinda aqaphele uma unomlando wokungezwani komzimba okukhulu kweminye imithi ye-monoclonal antibody.
Abantu abanezifo ezinzima ezisebenzayo bangase badinge ukulinda kuze kube yilapho ukutheleleka kuphathwa ngaphambi kokuqala i-crizanlizumab. Umuthi ungase uphazamise ikhono lomzimba wakho lokulwa nezifo, ngakho-ke isikhathi sibalulekile.
Abesifazane abakhulelwe nabancelisa ibele kufanele baxoxe ngezinhlobo zengozi nezinzuzo ngokucophelela nomhlinzeki wabo wezempilo, njengoba kunedatha yokuphepha elinganiselwe kulezi zimo. Udokotela wakho uzohlola izinzuzo ezingaba khona ngokumelene nanoma yiziphi izingozi ezingase zibe khona kuwe nomntwana wakho.
I-Crizanlizumab ithengiswa ngaphansi kwegama lomkhiqizo elithi Adakveo yi-Novartis Pharmaceuticals. Leli okwamanje yilo kuphela igama lomkhiqizo elitholakalayo lalo muthi e-United States.
Uma wamukela ukwelashwa kwakho, uzobona i-Adakveo kulebula lemithi kanye nasezirekhodini zakho zezokwelapha. Akukho okutholakala okufana ne-crizanlizumab ngalesi sikhathi, njengoba kungumuthi omusha osekusivikelweni selungelo lobunikazi.
Umshwalense wakho wokukhokhela kanye nezidingo zokugunyazwa kwangaphambili ngokuvamile zizobhekisela kokubili egameni elivamile (crizanlizumab) kanye negama lomkhiqizo (Adakveo) emibhalweni yabo.
Ngenkathi i-crizanlizumab ihlukile endleleni esebenza ngayo, kukhona eminye imithi etholakalayo ukusiza ukuphatha isifo samangqamuzana e-sickle nokunciphisa izinhlekelele zobuhlungu. Udokotela wakho angase acabange lezi ezinye izindlela uma i-crizanlizumab ingakulungele.
I-Hydroxyurea ivame ukuba yindlela yokuqala yokwelapha ukuvimbela izinhlekelele ze-sickle cell. Isebenza ngendlela ehlukile kune-crizanlizumab ngokwandisa ukukhiqizwa kwe-fetal hemoglobin, okusiza ukuvimbela amaseli abomvu egazi ekuguleni.
I-Voxelotor (Oxbryta) ngomunye umuthi omusha osebenza ngokwandisa ukuthanda kwe-hemoglobin ngomoya-mpilo, okusiza ukuvimbela ukugula. I-L-glutamine (Endari) iyisithasiselo se-amino acid esingasiza ukunciphisa imvamisa yezinhlekelele ngezindlela ezihlukene.
Udokotela wakho angase futhi ancome ukwelashwa okuhlanganisiwe, esebenzisa i-crizanlizumab kanye ne-hydroxyurea noma ezinye izindlela zokwelapha. Ukukhetha kuncike ezimpawini zakho ezithile, umlando wezokwelapha, nokuthi uqhubeke kanjani kahle ekwelashweni kwangaphambilini.
I-Crizanlizumab ne-hydroxyurea zisebenza ngezindlela ezihlukene ngokuphelele, ngakho ukuqhathanisa ngokuqondile akuhlali kuqondile. Zombili zingase zisebenze ekunciphiseni izinhlekelele zobuhlungu, kodwa zingase zisebenze kangcono kubantu abahlukene noma ezimweni ezihlukene.
I-Hydroxyurea isetshenziswe amashumi eminyaka futhi inesithombe sokuphepha esiqinile, kuyilapho i-crizanlizumab isisha ngemininingwane eminingi engaba khona yesikhathi eside. Kodwa-ke, abanye abantu abangayiphenduli kahle i-hydroxyurea bangathola inzuzo enkulu ku-crizanlizumab.
Odokotela abaningi empeleni basebenzisa le mithi ndawonye kunokukhetha enye ngaphezu kwenye. Indlela yokuhlanganisa ngezinye izikhathi inganikeza ukuvimbela okungcono kwezinkinga kunanoma iyiphi imithi yodwa. Udokotela wakho uzocabangela umlando wakho wezokwelapha, izimpendulo zokwelashwa zangaphambilini, nezintandokazi zakho siqu lapho enza izincomo.
I-Crizanlizumab ngokuvamile ingasetshenziswa ngokuphepha kubantu abanezifo zezinso ezilula kuya kweziphakathi, kodwa udokotela wakho uzokuqapha eduze uma unezinkinga zezinso. Umuthi awukhishwe ngokuyinhloko ngezinso, ngakho ukulungiswa kwemithamo ngokuvamile akudingekile.
Kodwa-ke, abantu abanesifo samangqamuzana e-sickle cell bavame ukuthuthukisa izinkinga zezinso ngokuhamba kwesikhathi, ngakho udokotela wakho uzofuna ukulandelela ukusebenza kwezinso zakho njalo kungakhathaliseki ukuthi usebenzisa i-crizanlizumab. Bangase bayalele ukuhlolwa kwegazi kaningi ukuze baqinisekise ukuthi izinso zakho zisebenza kahle.
Njengoba i-crizanlizumab inikezwa endaweni yokunakekelwa kwezempilo elawulwayo, ukweqisa akuvamile kakhulu. Umuthi ulinganiswa ngokucophelela futhi unikezwe ochwepheshe bezempilo abaqeqeshiwe abalandela imithetho eqinile.
Uma ukhathazekile ngomthamo wakho noma uba nezimpawu ezingavamile ngemuva kokufakwa, xhumana nomhlinzeki wakho wezempilo ngokushesha. Bangahlola izimpawu zakho futhi banikeze ukunakekelwa okufanele uma kudingeka. Isikhungo sokufaka sizokuqapha futhi nganoma yiziphi izimpawu zokungaphatheki kahle ngesikhathi nangemva kokwelashwa.
Uma uphuthelwa i-aphoyintimenti yakho yokufakwa komuthi, xhumana nomhlinzeki wakho wezempilo ngokushesha ngangokunokwenzeka ukuze uhlele kabusha. Kubalulekile ukugcina isimiso sakho sokwelashwa esivamile ukuze umuthi usebenze ngempumelelo.
Ngokuvamile, uma usheshe izinsuku ezimbalwa nje, ungaluthola ukufakwa komuthi bese uqhubeka nesimiso sakho esivamile sanyanga zonke. Kodwa-ke, uma uphuthelwe imithamo eminingi, udokotela wakho angase adinge ukulungisa uhlelo lwakho lokwelashwa noma akuqaphele eduze lapho uqala kabusha.
Isinqumo sokuyeka i-crizanlizumab kufanele senziwe ngaso sonke isikhathi ngokubonisana nomhlinzeki wakho wezempilo. Akufanele uyeke ukwelashwa wedwa, ngisho noma uzizwa ungcono noma ungabi nazinkinga zobuhlungu muva nje.
Udokotela wakho uzohlola njalo ukuthi ukwelashwa kusazuzisa yini kuwe, ngokuvamile njalo ezinyangeni ezimbalwa. Bazocabangela izinto ezinjengokuthi zingaki izinkinga zobuhlungu onazo, noma yimaphi imiphumela emibi oyitholayo, kanye nezinguquko esimweni sakho sempilo esiphelele.
Imithi eminingi yokugoma iphephile ukuyithola ngenkathi uthatha i-crizanlizumab, kodwa kufanele ngaso sonke isikhathi uxoxe ngemithi yokugoma ezayo nomhlinzeki wakho wezempilo kuqala. Bangase bancomise ukuhlela imithi yokugoma phakathi kokufakwa komuthi noma ukukuqapha eduze ngemva kokugonywa.
Imithi yokugoma ephilayo ingase idinge ukucatshangelwa okukhethekile, njengoba i-crizanlizumab ingase ithinte impendulo yakho yomzimba. Udokotela wakho uzobuyekeza umlando wakho wokugoma nezidingo zamanje ukuze aqinisekise ukuthi uhlala uvikelekile ezifweni ezingavikeleka ngenkathi uselashwa.
6Mpeople
Get clear medical guidance
on symptoms, medications, and lab reports.